Altered levels and molecular forms of granzyme k in plasma from septic patients.
about
Granzyme K activates protease-activated receptor-1Granzyme A activates another way to dieInter-alpha inhibitor protein administration improves survival from neonatal sepsis in miceGranzymes in age-related cardiovascular and pulmonary diseases.Cytotoxic and non-cytotoxic roles of the CTL/NK protease granzyme B.Death by a thousand cuts: granzyme pathways of programmed cell deathTranscriptomic signatures in whole blood of patients who acquire a chronic inflammatory response syndrome (CIRS) following an exposure to the marine toxin ciguatoxinPhenotype of NK Cells Determined on the Basis of Selected Immunological Parameters in Children Treated due to Acute Lymphoblastic Leukemia.The battlefield of perforin/granzyme cell death pathways.Granzyme K synergistically potentiates LPS-induced cytokine responses in human monocytes.Orphan granzymes find a home.Blessing or curse? Proteomics in granzyme research.Extracellular granzyme K mediates endothelial activation through the cleavage of protease-activated receptor-1.Granzymes A and K differentially potentiate LPS-induced cytokine response.Inflammation Combined with Ischemia Produces Myelin Injury and Plaque-Like Aggregates of Myelin, Amyloid-β and AβPP in Adult Rat Brain.Mouse granzyme K has pro-inflammatory potential.Systemic and local granzyme B levels are associated with disease activity, kidney damage and interferon signature in systemic lupus erythematosus.
P2860
Q28743018-C22180DB-C609-418C-AB7C-94F2E82D6EB9Q34002316-01B813D7-D4F1-4F3F-A7C3-E6E325BDC9AAQ34084719-061224CB-106F-4779-80E4-85C172E44547Q34097453-88FFCB34-B201-4FB9-ABF0-537DC8138603Q34120058-A7DC1E02-C439-4A80-B13A-CD2B092B97D5Q34588821-CE78FC7A-69C0-47DF-B02D-609BDC9C8D03Q35356235-60719FFB-EA04-46F8-9390-737A5FCE0F36Q37624221-0C81C3B8-6CC6-4681-B287-60DF97D99B94Q37633282-9385EEC1-0A6B-4A0D-A103-71E57748792BQ37725297-A1BB5B33-E308-4F12-B7F6-3F74000711D6Q37763995-19FDBAF3-E309-4224-A2E4-D06AF0E51498Q38200060-41DB453F-41A9-4138-9E32-BD19FD01E0BEQ38789342-A11931AB-5665-45DF-91AC-6BA9DF79AA07Q40393562-8E04A241-429A-40AB-B264-F1F3729CA2E3Q42144566-2AD5B56F-3D9F-411F-8A72-32596D3976D5Q42790753-F8D14058-3DA6-4481-A923-81E781A24C22Q47714924-095D2310-D958-41BA-B27E-9E4BA102BC9C
P2860
Altered levels and molecular forms of granzyme k in plasma from septic patients.
description
2007 nî lūn-bûn
@nan
2007 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Altered levels and molecular forms of granzyme k in plasma from septic patients.
@ast
Altered levels and molecular forms of granzyme k in plasma from septic patients.
@en
Altered levels and molecular forms of granzyme k in plasma from septic patients.
@nl
type
label
Altered levels and molecular forms of granzyme k in plasma from septic patients.
@ast
Altered levels and molecular forms of granzyme k in plasma from septic patients.
@en
Altered levels and molecular forms of granzyme k in plasma from septic patients.
@nl
prefLabel
Altered levels and molecular forms of granzyme k in plasma from septic patients.
@ast
Altered levels and molecular forms of granzyme k in plasma from septic patients.
@en
Altered levels and molecular forms of granzyme k in plasma from septic patients.
@nl
P2093
P1433
P1476
Altered levels and molecular forms of granzyme k in plasma from septic patients
@en
P2093
Andrew Sucov
Edward Siryaporn
Flor M Trespalcios
Loren D Fast
Marijana Rucevic
Yow-Pin Lim
P304
P356
10.1097/01.SHK.0000246905.24895.E5
P577
2007-05-01T00:00:00Z